Business

The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.

Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.  

Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.

The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.

Updesh Dosanjh, practice leader of technology solutions for lQVIA, discusses ensuring fairness while using AI in clinical trials, the value of digital twins and the necessity of building and consistently adapting frameworks around AI use.  

Also, BetterSpace in India has received pre-seed funding to develop mobile mental health games.

The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.

Davidi Vortman, CEO of UltraSight, discusses the company's AI-driven cardiac-imaging technology that helps providers quickly and efficiently triage patients and the ways the FDA-cleared system is used in the U.S. and globally.  

Dr. Nele Jessel, chief medical officer at Athenahealth, discusses how bringing behavioral health tools, such as telehealth, into the primary care setting can improve access to services and reduce the stigma around mental health conditions.  

Foley & Lardner's Nathaniel Lacktman and Louis Lehot discuss which categories of digital health hold the most potential for M&As and why in this contributed piece.